BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27103024)

  • 1. Comprehensive Quality Control of the ITG 68Ge/68Ga Generator and Synthesis of 68Ga-DOTATOC and 68Ga-PSMA-HBED-CC for Clinical Imaging.
    Amor-Coarasa A; Schoendorf M; Meckel M; Vallabhajosula S; Babich JW
    J Nucl Med; 2016 Sep; 57(9):1402-5. PubMed ID: 27103024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuation of comprehensive quality control of the itG
    Amor-Coarasa A; Kelly JM; Gruca M; Nikolopoulou A; Vallabhajosula S; Babich JW
    Nucl Med Biol; 2017 Oct; 53():37-39. PubMed ID: 28803001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of Labeling PSMA
    Eppard E; Homann T; de la Fuente A; Essler M; Rösch F
    J Nucl Med; 2017 Mar; 58(3):432-437. PubMed ID: 28082433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated production of [
    Garcia-Arguello SF; Lopez-Lorenzo B; Ruiz-Cruces R
    J Labelled Comp Radiopharm; 2019 Mar; 62(3):146-153. PubMed ID: 30672007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a Single Vial Kit Solution for Radiolabeling of 68Ga-DKFZ-PSMA-11 and Its Performance in Prostate Cancer Patients.
    Ebenhan T; Vorster M; Marjanovic-Painter B; Wagener J; Suthiram J; Modiselle M; Mokaleng B; Zeevaart JR; Sathekge M
    Molecules; 2015 Aug; 20(8):14860-78. PubMed ID: 26287143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of [(68)Ga]PSMA-11 for PET-CT imaging using a manual synthesis module and organic matrix based (68)Ge/(68)Ga generator.
    Nanabala R; Anees MK; Sasikumar A; Joy A; Pillai MR
    Nucl Med Biol; 2016 Aug; 43(8):463-9. PubMed ID: 27231953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance and long-term consistency of five Galliform 68Ge/68Ga generators used for clinical Ga-68 preparations over a 4 year period.
    Sammartano A; Migliari S; Scarlattei M; Baldari G; Serreli G; Lazzara C; Garau L; Ghetti C; Ruffini L
    Nucl Med Commun; 2022 May; 43(5):568-576. PubMed ID: 35190517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Processing of generator-produced 68Ga for medical application.
    Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
    J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Otto: a 4.04 GBq (109 mCi)
    Waterhouse NN; Amor-Coarasa A; Nikolopoulou A; Babich JW
    EJNMMI Radiopharm Chem; 2020 Feb; 5(1):5. PubMed ID: 32016646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of 68Ga-PSMA HBED-CC PET for the Assessment of Lymph Node Metastases in Prostate Cancer Patients with Biochemical Recurrence: Comparison with Histopathology After Salvage Lymphadenectomy.
    Rauscher I; Maurer T; Beer AJ; Graner FP; Haller B; Weirich G; Doherty A; Gschwend JE; Schwaiger M; Eiber M
    J Nucl Med; 2016 Nov; 57(11):1713-1719. PubMed ID: 27261524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing capacity and synthesis of [68Ga]68-Ga-PSMA-HBED-CC with the lyophilized ready-to-use kit for nuclear pharmacy applications.
    Golan H; Esa M; Moshkoviz K; Feldhaim A; Hoch B; Shalom E
    Nucl Med Commun; 2020 Sep; 41(9):986-990. PubMed ID: 32796488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators.
    Tworowska I; Ranganathan D; Thamake S; Delpassand E; Mojtahedi A; Schultz MK; Zhernosekov K; Marx S
    Nucl Med Biol; 2016 Jan; 43(1):19-26. PubMed ID: 26702783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of (68)Ge/(68)Ga generator processing by chemical purification for routine clinical application of (68)Ga-DOTATOC.
    Asti M; De Pietri G; Fraternali A; Grassi E; Sghedoni R; Fioroni F; Roesch F; Versari A; Salvo D
    Nucl Med Biol; 2008 Aug; 35(6):721-4. PubMed ID: 18678358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of
    Rodnick ME; Sollert C; Stark D; Clark M; Katsifis A; Hockley BG; Parr DC; Frigell J; Henderson BD; Bruton L; Preshlock S; Abghari-Gerst M; Piert MR; Fulham MJ; Eberl S; Gagnon K; Scott PJH
    Nat Protoc; 2022 Apr; 17(4):980-1003. PubMed ID: 35246649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long-term Quality Control Test of a
    Tomita S; Higashikawa K; Ueno S; Mizuno Y; Tazawa S; Kuge Y
    Kaku Igaku; 2021; 58(1):47-58. PubMed ID: 34108303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a simple kit-based method for preparation of pharmaceutical-grade ⁶⁸Ga-DOTATOC.
    Asti M; Iori M; Capponi PC; Rubagotti S; Fraternali A; Versari A
    Nucl Med Commun; 2015 May; 36(5):502-10. PubMed ID: 25695611
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Vats K; Sharma R; Sarma HD; Satpati D; Dash A
    Anticancer Agents Med Chem; 2018; 18(9):1289-1294. PubMed ID: 29546835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals.
    Eppard E; Wuttke M; Nicodemus PL; Rösch F
    J Nucl Med; 2014 Jun; 55(6):1023-8. PubMed ID: 24752674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-HBED-CC-PSMA PET/CT.
    Lütje S; Gomez B; Cohnen J; Umutlu L; Gotthardt M; Poeppel TD; Bockisch A; Rosenbaum-Krumme S
    Clin Nucl Med; 2017 Jan; 42(1):20-25. PubMed ID: 27846003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved purification of cyclotron [
    Wang IE; Brooks AF; Clark M; Morrissette LJ; Scott PJH
    Nucl Med Biol; 2024; 130-131():108892. PubMed ID: 38447298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.